GURUFOCUS.COM » STOCK LIST » USA » OTCPK » Biomark Diagnostics Inc (OTCPK:BMKDF) » Definitions » Profitability Rank
Switch to:

Biomark Diagnostics (OTCPK:BMKDF) Profitability Rank

: 1 (As of Sep. 2022)
View and export this data going back to 2015. Start your Free Trial

Biomark Diagnostics has the Profitability Rank of 1. It has had trouble to make a profit.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Biomark Diagnostics's Operating Margin % for the quarter that ended in Sep. 2022 was -1,214.63%. As of today, Biomark Diagnostics's Piotroski F-Score is 2.


Biomark Diagnostics (OTCPK:BMKDF) Profitability Rank Competitive Comparison

For the Diagnostics & Research subindustry, Biomark Diagnostics's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Biomark Diagnostics (OTCPK:BMKDF) Profitability Rank Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Biomark Diagnostics's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Biomark Diagnostics's Profitability Rank falls into.



Biomark Diagnostics Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Biomark Diagnostics has the Profitability Rank of 1. It has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Biomark Diagnostics's Operating Margin % for the quarter that ended in Sep. 2022 is calculated as:

Operating Margin %=Operating Income (Q: Sep. 2022 ) / Revenue (Q: Sep. 2022 )
=-0.37334132993478 / 0.030736936801859
=-1,214.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Biomark Diagnostics has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank


Biomark Diagnostics Profitability Rank Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomark Diagnostics (OTCPK:BMKDF) Business Description

Biomark Diagnostics logo
Traded in Other Exchanges
Address
130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2
Biomark Diagnostics Inc is a Canada based oncology-focused company. It is engaged in the development of advanced-stage cancer diagnostic business. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection.

Biomark Diagnostics (OTCPK:BMKDF) Headlines

No Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
premium membership